GBIO Generation Bio Co.

Nasdaq generationbio.com


$ 5.59 $ -0.22 (-3.88 %)    

Wednesday, 29-Oct-2025 15:59:59 EDT
QQQ $ 632.93 $ 0.00 (0 %)
DIA $ 474.55 $ 0.00 (0 %)
SPY $ 685.00 $ 0.00 (0 %)
TLT $ 90.39 $ 0.00 (0 %)
GLD $ 365.76 $ 0.00 (0 %)
$ 5.57
$ 5.75
$ 5.50 x 107
$ 5.68 x 50
-- - --
$ 3.00 - $ 25.70
96,345
na
37.52M
$ 1.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-06-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-18-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 generation-bio-president-ceo-geoff-mcdonough-to-become-board-chair-effective-oct-31-yalonda-howze-names-interim-ceo-president

Generation Bio Co. (NASDAQ:GBIO), a biotechnology company working to change what's possible for people living with T cell-d...

 needham-reiterates-buy-on-generation-bio-maintains-15-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $15 price target.

 wedbush-downgrades-generation-bio-to-neutral-maintains-price-target-to-7

Wedbush analyst David Nierengarten downgrades Generation Bio (NASDAQ:GBIO) from Outperform to Neutral and maintains the pric...

 why-sapiens-international-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket

Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday...

 generation-bio-q2-eps-312-misses-262-estimate-sales-765000k-miss-2139m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(3.12) per share which missed the analyst consensus estimate of $(2....

 generation-bio-has-been-granted-australian-patent-number-2019210034-titled-closed-ended-dna-vectors-obtainable-from-cell-free-synthesis-and-process-for-obtaining-cedna-vectors-for-gene-therapy

https://ipsearch.ipaustralia.gov.au/patents/2019210034

 needham-reiterates-buy-on-generation-bio-maintains-8-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $8 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION